Page last updated: 2024-10-25

ciglitazone and Emphysema

ciglitazone has been researched along with Emphysema in 2 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Emphysema: A pathological accumulation of air in tissues or organs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelly, NJ1
Shapiro, SD1
Shan, M1
You, R1
Yuan, X1
Frazier, MV1
Porter, P1
Seryshev, A1
Hong, JS1
Song, LZ1
Zhang, Y1
Hilsenbeck, S1
Whitehead, L1
Zarinkamar, N1
Perusich, S1
Corry, DB1
Kheradmand, F1

Other Studies

2 other studies available for ciglitazone and Emphysema

ArticleYear
PPARĪ³ in emphysema: blunts the damage and triggers repair?
    The Journal of clinical investigation, 2014, Volume: 124, Issue:3

    Topics: Animals; Emphysema; Humans; PPAR gamma; Smoking; Thiazolidinediones

2014
Agonistic induction of PPARĪ³ reverses cigarette smoke-induced emphysema.
    The Journal of clinical investigation, 2014, Volume: 124, Issue:3

    Topics: Alveolar Epithelial Cells; Animals; Case-Control Studies; Cells, Cultured; Coculture Techniques; Den

2014